These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32975514)

  • 1. POMK regulates dystroglycan function via LARGE1-mediated elongation of matriglycan.
    Walimbe AS; Okuma H; Joseph S; Yang T; Yonekawa T; Hord JM; Venzke D; Anderson ME; Torelli S; Manzur A; Devereaux M; Cuellar M; Prouty S; Ocampo Landa S; Yu L; Xiao J; Dixon JE; Muntoni F; Campbell KP
    Elife; 2020 Sep; 9():. PubMed ID: 32975514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy.
    Okuma H; Hord JM; Chandel I; Venzke D; Anderson ME; Walimbe AS; Joseph S; Gastel Z; Hara Y; Saito F; Matsumura K; Campbell KP
    Elife; 2023 Feb; 12():. PubMed ID: 36723429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma.
    Beltrán D; Anderson ME; Bharathy N; Settelmeyer TP; Svalina MN; Bajwa Z; Shern JF; Gultekin SH; Cuellar MA; Yonekawa T; Keller C; Campbell KP
    Skelet Muscle; 2019 May; 9(1):11. PubMed ID: 31054580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HNK-1 sulfotransferase modulates α-dystroglycan glycosylation by 3-O-sulfation of glucuronic acid on matriglycan.
    Sheikh MO; Venzke D; Anderson ME; Yoshida-Moriguchi T; Glushka JN; Nairn AV; Galizzi M; Moremen KW; Campbell KP; Wells L
    Glycobiology; 2020 Sep; 30(10):817-829. PubMed ID: 32149355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of protein O-mannose kinase reveals a unique active site architecture.
    Zhu Q; Venzke D; Walimbe AS; Anderson ME; Fu Q; Kinch LN; Wang W; Chen X; Grishin NV; Huang N; Yu L; Dixon JE; Campbell KP; Xiao J
    Elife; 2016 Nov; 5():. PubMed ID: 27879205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D structural analysis of protein O-mannosyl kinase, POMK, a causative gene product of dystroglycanopathy.
    Nagae M; Mishra SK; Neyazaki M; Oi R; Ikeda A; Matsugaki N; Akashi S; Manya H; Mizuno M; Yagi H; Kato K; Senda T; Endo T; Nogi T; Yamaguchi Y
    Genes Cells; 2017 Apr; 22(4):348-359. PubMed ID: 28251761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.
    Yoshida-Moriguchi T; Yu L; Stalnaker SH; Davis S; Kunz S; Madson M; Oldstone MB; Schachter H; Wells L; Campbell KP
    Science; 2010 Jan; 327(5961):88-92. PubMed ID: 20044576
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Yonekawa T; Rauckhorst AJ; El-Hattab S; Cuellar MA; Venzke D; Anderson ME; Okuma H; Pewa AD; Taylor EB; Campbell KP
    Sci Adv; 2022 May; 8(21):eabn0379. PubMed ID: 35613260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues.
    Inamori K; Willer T; Hara Y; Venzke D; Anderson ME; Clarke NF; Guicheney P; Bönnemann CG; Moore SA; Campbell KP
    J Biol Chem; 2014 Oct; 289(41):28138-48. PubMed ID: 25138275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Modeling of a GT-A Fold in the α-Dystroglycan Glycosylating Enzyme LARGE1.
    Righino B; Bozzi M; Pirolli D; Sciandra F; Bigotti MG; Brancaccio A; De Rosa MC
    J Chem Inf Model; 2020 Jun; 60(6):3145-3156. PubMed ID: 32356985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function.
    Yoshida-Moriguchi T; Willer T; Anderson ME; Venzke D; Whyte T; Muntoni F; Lee H; Nelson SF; Yu L; Campbell KP
    Science; 2013 Aug; 341(6148):896-9. PubMed ID: 23929950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane.
    Yoshida-Moriguchi T; Campbell KP
    Glycobiology; 2015 Jul; 25(7):702-13. PubMed ID: 25882296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Matriglycan by Dual Exoglycosidase Digestion of α-Dystroglycan.
    Chandel I; Campbell KP
    Bio Protoc; 2023 Sep; 13(18):e4827. PubMed ID: 37753476
    [No Abstract]   [Full Text] [Related]  

  • 14. Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding.
    Patnaik SK; Stanley P
    J Biol Chem; 2005 May; 280(21):20851-9. PubMed ID: 15788414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscular dystrophy-dystroglycanopathy in a family of Labrador retrievers with a LARGE1 mutation.
    Shelton GD; Minor KM; Guo LT; Friedenberg SG; Cullen JN; Hord JM; Venzke D; Anderson ME; Devereaux M; Prouty SJ; Handelman C; Campbell KP; Mickelson JR
    Neuromuscul Disord; 2021 Nov; 31(11):1169-1178. PubMed ID: 34654610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
    Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R
    Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of α-dystroglycan.
    Kuga A; Kanagawa M; Sudo A; Chan YM; Tajiri M; Manya H; Kikkawa Y; Nomizu M; Kobayashi K; Endo T; Lu QL; Wada Y; Toda T
    J Biol Chem; 2012 Mar; 287(12):9560-7. PubMed ID: 22270369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycomic analyses of mouse models of congenital muscular dystrophy.
    Stalnaker SH; Aoki K; Lim JM; Porterfield M; Liu M; Satz JS; Buskirk S; Xiong Y; Zhang P; Campbell KP; Hu H; Live D; Tiemeyer M; Wells L
    J Biol Chem; 2011 Jun; 286(24):21180-90. PubMed ID: 21460210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a short, single site matriglycan that maintains neuromuscular function in the mouse.
    Yang T; Chandel I; Gonzales M; Okuma H; Prouty SJ; Zarei S; Joseph S; Garringer KW; Landa SO; Yonekawa T; Walimbe AS; Venzke DP; Anderson ME; Hord JM; Campbell KP
    bioRxiv; 2023 Dec; ():. PubMed ID: 38187633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POMK mutations disrupt muscle development leading to a spectrum of neuromuscular presentations.
    Di Costanzo S; Balasubramanian A; Pond HL; Rozkalne A; Pantaleoni C; Saredi S; Gupta VA; Sunu CM; Yu TW; Kang PB; Salih MA; Mora M; Gussoni E; Walsh CA; Manzini MC
    Hum Mol Genet; 2014 Nov; 23(21):5781-92. PubMed ID: 24925318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.